Documentos de Urrunaga-Pastor D. | REDI

Regresar

Mostrando 3 resultados de: 3

Subtipo de publicación

Publisher

Travel Medicine and Infectious Disease(1)

Área temáticas

Enfermedades(3)

Escultura hasta aprox. 500(1)

Fisiología humana(1)

Grupos de personas(1)

Medicina forense; incidencia de enfermedades(1)

Área de conocimiento

Ginecología(2)

Inmunología(1)

Medicina interna(1)

Año de Publicación

Origen

Palabras Claves

Female sexual function index(2)

Sexual Dysfunction(2)

Doses (source: MeSH)(1)

Female orgasmic dysfunction and severe climacteric symptomatology in women aged 40 to 59years: an independent association from an analysis of a multicenter Latin American study

Abstract: Objective:To evaluate the association between the severity of climacteric symptoms (CS) and orgasmic

Palabras claves:

climacteric, Female sexual function index, Latin American, MENOPAUSE, menopause rating scale, Sexual Dysfunction

Andrés Calle, Ascanio Rafael Bencosme, Baron G., Belzares E., Daysi Navarro, Eliana Ojeda, Flores D., Humberto Izaguirre, J. E. Blümel, Leon-Leon P., Lima S., Maríá Soledad Vallejo, Maríá Teresa Espinoza, Mezones-Holgún E., Moisés Apolaya-Segura, Monterrosa A., Mostajo D., Peter A. Chedraui, Soto E., Tserotas K., Urrunaga-Pastor D.

Low sexual function is associated with menopausal status in mid-aged women with human immunodeficiency virus infection

Abstract: Objective:To assess the association between menopausal status and female sexual function among mid-a

Palabras claves:

Female sexual function index, Highly active antiretroviral therapy, human immunodeficiency virus, MENOPAUSE, Perú, Sexual Dysfunction, Women

Al-Kassab-Córdova A., Arriola-Montenegro J., Blümel J.E., Cutimanco-Pacheco V., Faustino R. Pérez-López, Mezones-Holgún E., Niño-García R., Peter A. Chedraui, Urrunaga-Pastor D., Zeta L.A.

Post-vaccination seropositivity against SARS-CoV-2 in peruvian health workers vaccinated with BBIBP-CorV (Sinopharm)

Abstract: Objective: To estimate the prevalence of post-vaccination seropositivity against SARS-CoV-2 and iden

Palabras claves:

Antibodies, covid-19, Doses (source: MeSH), serology, Vaccine

Alvizuri-Pastor S., Carrillo-Ramos E., Contreras-Macazana R., Cvetkovic-Vega A., Fernandez-Bolivar L., Figueroa-Montes L.E., Grande-Castro N., Lecca-Rengifo D., Maguiña J.L., Moisés Apolaya-Segura, Neyra-Vera I., Oyanguren-Miranda M., Sagástegui A., Soto-Becerra P., Urrunaga-Pastor D.